A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 15678055)

Published in J Thorac Cardiovasc Surg on February 01, 2005

Authors

S Keshavjee1, R D Davis, M R Zamora, M de Perrot, G A Patterson

Author Affiliations

1: University of Toronto, Toronto, Ontario, Canada. shaf.keshavjee@uhn.on.ca <shaf.keshavjee@uhn.on.ca>

Articles citing this

Myasthenia gravis: past, present, and future. J Clin Invest (2006) 3.06

Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. Expert Rev Mol Med (2009) 2.77

Complement 5a receptor inhibition improves renal allograft survival. J Am Soc Nephrol (2008) 1.72

Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo. Blood (2006) 1.05

Novel complement inhibitor limits severity of experimentally myasthenia gravis. Ann Neurol (2009) 1.01

Primary graft dysfunction. Semin Respir Crit Care Med (2013) 0.93

Targeting complement component 5a promotes vascular integrity and limits airway remodeling. Proc Natl Acad Sci U S A (2013) 0.90

Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation. Interact Cardiovasc Thorac Surg (2015) 0.89

Complement-mediated microvascular injury leads to chronic rejection. Adv Exp Med Biol (2013) 0.85

Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation. Am J Respir Crit Care Med (2014) 0.84

Complement system in lung disease. Am J Respir Cell Mol Biol (2014) 0.78

Primary graft dysfunction: lessons learned about the first 72 h after lung transplantation. Curr Opin Organ Transplant (2015) 0.78

Effects of intraoperative inhaled iloprost on primary graft dysfunction after lung transplantation: A retrospective single center study. Medicine (Baltimore) (2016) 0.75

Viral-derived complement inhibitors: current status and potential role in immunomodulation. Exp Biol Med (Maywood) (2016) 0.75

Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective. Clin Exp Immunol (2015) 0.75

Complement in Lupus Nephritis: New Perspectives. Kidney Dis (Basel) (2015) 0.75

Articles by these authors

(truncated to the top 100)

Results of single-lung transplantation for bilateral pulmonary fibrosis. The Toronto Lung Transplant Group. N Engl J Med (1990) 2.85

A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant (1993) 2.69

Primary cysts and neoplasms of the mediastinum: recent changes in clinical presentation, methods of diagnosis, management, and results. Ann Thorac Surg (1987) 2.44

Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg (1995) 2.44

A mouse model of orthotopic vascularized aerated lung transplantation. Am J Transplant (2007) 2.16

Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg (1996) 2.15

Infections in patients with cystic fibrosis following lung transplantation. Chest (1997) 1.98

Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i). Circ Res (2000) 1.88

Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome. Chest (2001) 1.74

Chronic thromboembolic pulmonary hypertension. Eur Respir J (2004) 1.74

CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant (2006) 1.63

The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg (1999) 1.59

Donor lung procurement: assessment and operative technique. Ann Thorac Surg (1993) 1.54

The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man. Clin Pharmacol Ther (1970) 1.54

Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg (1987) 1.54

Community respiratory viral infection in adult lung transplant recipients. Chest (1998) 1.53

Lung transplantation with donation after circulatory determination of death donors and the impact of ex vivo lung perfusion. Am J Transplant (2015) 1.51

Survival in sensitized lung transplant recipients with perioperative desensitization. Am J Transplant (2015) 1.51

Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Ann Thorac Surg (1997) 1.48

Bleomycin-induced interstitial pneumonia in dogs. Thorax (1971) 1.47

Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J Thorac Cardiovasc Surg (1986) 1.47

Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a ten-year institutional experience. J Thorac Cardiovasc Surg (2000) 1.46

Is there ever a role for salvage operations in limited small-cell lung cancer? J Thorac Cardiovasc Surg (1991) 1.46

Outcome of Medicare patients with emphysema selected for, but denied, a lung volume reduction operation. Ann Thorac Surg (1998) 1.45

Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant (2009) 1.43

Diagnostic yield of bronchoscopies after isolated lung transplantation. Chest (1996) 1.42

Single lung transplantation and closure of patent ductus arteriosus for Eisenmenger's syndrome. Toronto Lung Transplant Group. J Thorac Cardiovasc Surg (1990) 1.42

Inducible nitric oxide synthase is expressed during experimental acute lung allograft rejection. J Heart Lung Transplant (1997) 1.41

HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation (1998) 1.41

Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol (1997) 1.40

Preharvest nitroprusside flush improves posttransplantation lung function. J Heart Lung Transplant (1997) 1.40

Comparison of PCR, antigenemia assay, and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation. J Clin Microbiol (2000) 1.39

Strategies to increase limited donor resources. Eur Respir J (2004) 1.38

Separate extraction of cardiac and pulmonary grafts from a single organ donor. Ann Thorac Surg (1988) 1.37

Predictors of cognitive decline after cardiac operation. Ann Thorac Surg (1995) 1.28

Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation (1999) 1.28

Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant (2005) 1.27

Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg (1998) 1.26

The toxicity of Escherichia coli L-asparaginase. Cancer Res (1969) 1.25

Double-lung transplant for advanced chronic obstructive lung disease. Am Rev Respir Dis (1989) 1.23

Evaluation of suicidal patients: the SAD PERSONS scale. Psychosomatics (1983) 1.22

Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol (1997) 1.22

Smoking cessation and lung cancer resection. Chest (1996) 1.21

Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation. Am J Transplant (2012) 1.19

Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. Am J Transplant (2008) 1.19

Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg (1997) 1.18

Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. Chest (2000) 1.18

Supradiaphragmatic ligation of the thoracic duct in intractable chylous fistula. Ann Thorac Surg (1981) 1.17

CCR2 regulates monocyte recruitment as well as CD4 T1 allorecognition after lung transplantation. Am J Transplant (2010) 1.17

Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res (1996) 1.17

Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies. Vaccine (2000) 1.15

Chronic aspiration of gastric fluid induces the development of obliterative bronchiolitis in rat lung transplants. Am J Transplant (2008) 1.15

Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg (1995) 1.15

Successful treatment of a pseudoaneurysm of the cystic artery with microcoil embolization. J Vasc Interv Radiol (1999) 1.15

Pancreatic islet cell tumors produced by the combined action of streptozotocin and nicotinamide. Proc Soc Exp Biol Med (1971) 1.14

Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patients. Ann Surg (1999) 1.14

Surgeons' concern and practices of protection against bloodborne pathogens. Ann Surg (1998) 1.12

Experiences of women in cardiothoracic surgery. A gender comparison. Arch Surg (1996) 1.11

Hapten-induced primary and memory humoral responses are inhibited by the infusion of anti-CD20 monoclonal antibody (IDEC-C2B8, Rituximab). Clin Immunol (2001) 1.10

Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema. J Heart Lung Transplant (1999) 1.10

Comparison of early functional results after volume reduction or lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg (1996) 1.10

Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg (1995) 1.10

Extracellular superoxide dismutase transgene overexpression preserves postischemic myocardial function in isolated murine hearts. Circulation (1996) 1.10

Increasing lung allocation scores predict worsened survival among lung transplant recipients. Am J Transplant (2010) 1.09

The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation (2000) 1.09

Redo lung transplantation: a North American-European experience. J Heart Lung Transplant (1993) 1.08

Bilateral lung transplantation for cystic fibrosis. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg (1992) 1.08

Use of silicone stents in the management of airway problems. Ann Thorac Surg (1989) 1.08

Bronchial dehiscence in lung transplantation: CT evaluation. Radiology (1995) 1.07

Ex vivo adenoviral-mediated gene transfer to lung isografts during cold preservation. Ann Thorac Surg (1997) 1.07

Evaluation of a prototype esophageal detection device. Acad Emerg Med (1995) 1.07

Laparoscopic antireflux surgery in the lung transplant population. Surg Endosc (2002) 1.07

Clinical efficacy of two dentin desensitizing agents. Am J Dent (1999) 1.06

Perioperative mortality and major cardio-pulmonary complications after lung surgery for non-small cell carcinoma. Eur J Cardiothorac Surg (1999) 1.06

Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant (2006) 1.06

Recurrence of diffuse panbronchiolitis after lung transplantation. Am J Respir Crit Care Med (1995) 1.05

Human melanoma cells express functional endothelin-1 receptors. Biochem Biophys Res Commun (1994) 1.05

Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Transplantation (1999) 1.04

Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant (2008) 1.04

Baseline 6-min walk distance predicts survival in lung transplant candidates. Am J Transplant (2008) 1.04

The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest (1998) 1.03

Prolonged function of macrophage, von Willebrand factor-deficient porcine pulmonary xenografts. Am J Transplant (2006) 1.03

Pathologic interpretation of transbronchial biopsy for acute rejection of lung allograft is highly variable. Am J Transplant (2011) 1.02

Myocardial function in hearts with transgenic overexpression of the G protein-coupled receptor kinase 5. Ann Thorac Surg (2001) 1.02

The value of adjuvant radiotherapy in pulmonary and chest wall resection for bronchogenic carcinoma. Ann Thorac Surg (1982) 1.02

Preoperative prediction for the use of cardiopulmonary bypass in lung transplantation. J Thorac Cardiovasc Surg (1993) 1.02

A comparative study of thoracoscopic vs open removal of benign neurogenic mediastinal tumors. Chest (1996) 1.01

Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertension. Circulation (1998) 1.01

Sphingosine 1-phosphate inhibits ischemia reperfusion injury following experimental lung transplantation. Am J Transplant (2007) 1.00

Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature. Medicine (Baltimore) (1996) 1.00

Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation. Transplant Proc (1999) 1.00

Major histocompatibility complex expression and lung ischemia-reperfusion in rats. Ann Thorac Surg (1996) 1.00

Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am J Transplant (2001) 1.00

Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies. Ann Thorac Surg (1999) 1.00

A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study. J Thorac Cardiovasc Surg (1989) 0.99

Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg (1996) 0.99

Platinate toxicity: past, present, and prospects. Cancer Treat Rep (1980) 0.98

Precision cautery excision of pulmonary lesions. Ann Thorac Surg (1986) 0.97

Cultured human keratinocytes synthesize and secrete endothelin-1. J Invest Dermatol (1993) 0.97

Single lung transplantation for pulmonary hypertension. Single institution experience in 34 patients. Circulation (1995) 0.97